Next 10 |
REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results for the first quarter 2024 on Wednesday, ...
2024-04-24 08:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-12 11:34:12 ET More on S&P 500 Index: Sticking With The More Optimistic View Where We Stand Sorry Campers, The Fed Is Not Riding To The Rescue Nasdaq, S&P, Dow slip as major banks kick off earnings season Nasdaq, S&P climb, Dow end...
2024-04-12 08:30:02 ET Needham analyst issues BUY recommendation for RVMD on April 12, 2024 06:50AM ET. The previous analyst recommendation was Buy. RVMD was trading at $37.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
2024-04-12 04:14:54 ET Summary Revolution Medicines raised $238 million via its 2020 IPO, and 4 years later has grown its share price by ~30%, bringing its market cap valuation to $6 billion. The company is pioneering a unique precision-based approach to developing oncology drugs ...
A look at the top 10 most actives in the United States Marin Software Incorporated (MRIN) rose 126.3% to $0.6497 on volume of 228,672,822 shares PROSHARES TRUST (SQQQ) rose 2.7% to $10.9 on volume of 177,760,238 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 4.9% to $3.43 ...
Shares of Revolution Medicines, Inc. (NASDAQ: RVMD) traded at a new 52-week high today and are currently trading at $35.52. So far today, approximately 1.12M shares have been exchanged, as compared to an average 30-day volume of 1.43M shares. Revolution Medicines, Inc., a clinical-stage preci...
2024-04-10 10:02:03 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Well...
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 2.2% to $3.3405 on volume of 57,142,172 shares Adial Pharmaceuticals Inc (ADIL) rose 97.3% to $2.2299 on volume of 50,603,026 shares Jaguar Health Inc. (JAGX) rose 24.2% to $0.11...
REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the publication of a peer-reviewed research paper in Cancer Discovery. Th...
News, Short Squeeze, Breakout and More Instantly...
Revolution Medicines Inc. Company Name:
RVMD Stock Symbol:
NASDAQ Market:
REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing ta...
REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results for the first quarter 2024 on Wednesday, ...
2024-04-24 08:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...